Performance evaluation of an adalimumab biosimilar autoinjector and its reference device: comparative use human factors study in patients with rheumatoid arthritis and juvenile idiopathic arthritis
A Comparative Use Human Factors study was conducted to assess whether the injection success rate (SR) with biosimilar adalimumab-fkjp (Bios-ADA) autoinjector (Hulio®) is comparable to reference adalimumab (Ref-ADA) autoinjector (Humira®), accounting for design differences, including the absence of a...
Na minha lista:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis Group
2026-12-01
|
| coleção: | Drug Delivery |
| Assuntos: | |
| Acesso em linha: | https://www.tandfonline.com/doi/10.1080/10717544.2026.2649991 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
